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The world is becoming increasingly under the threat of entering the 
“post-antibiotic era”, an era in which the rate of death from common 
bacterial infections is higher than from cancer. Pseudomonas aerugi-
nosa is an opportunistic multidrug-resistant pathogen and it is the 
main cause of morbidity and mortality in hospitalized patients and im-
munocompromised individuals. P. aeruginosa is considered as one of 
the most common pathogens, which can be highly difficult to cure its 
infection in human body. It is one of the major causes of nosocomial 
and ventilator-associated pneumonia characterized by high incidence 
and fatality rates. In addition, P. aeruginosa is commonly associated 
with chronic lung infections in individuals with cystic fibrosis. Thus, 
multidrug-resistant strains of P. aeruginosa contribute to high morta-
lity in patients suffering of its infections.
One of the major virulence factors for this pathogen is its ability 
to form biofilms. This biological developed protects the pathogen 
from host immunity and contributes to its antimicrobial resistance. It 
is estimated that about 80% of infectious diseases are due to biofilm 
formation. Biofilm forming ability and antimicrobial resistance of this 
pathogen lead to many persistent and chronic bacterial infections.
Here, we review recent studies that are demonstrating how P. aeru-
ginosa biofilm formation contributes to persistent chronic infection 
and its ability to resist antibiotic treatment. Thus, understanding the 
mechanisms of biofilm development of P. aeruginosa in association 
with resistance to antimicrobial agents is crucial to find way(s) for 
successful therapeutic interventions.
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Introduction
Pseudomonas aeruginosa is a Gram-negative ba-
cillus, β-hemolytic, monotrichous bacterium with 
grape-like odor. It grows well at 25°C to 37°C, 
and its ability to grow at 42°C constitutes a dis-
tinguishing character from many other species. P. 
aeruginosa strains produce four types of pigments 
pyocyanin, pyoverdin, pyorubin, pyomelanin [1]. 
The extensive metabolic diversity and the flexibi-
lity of Pseudomonas spp. allow the organism to 
grow in a wide variety of environments, nutrient 
sources and to be an opportunistic pathogen. In 
particular, P. aeruginosa is able to form biofilms, 
develops antibiotic resistance, produces virulence 
factors, and rapidly evolves in the course of a chro-
nic infection [1]. 
Role of P. aeruginosa virulence factors 
Pseudomonas aeruginosa is a common health care 
associated pathogen. Numerous clinical conditions 
are highly associated with P. aeruginosa infection 
such as cystic fibrosis, burns, urinary catheterization, 
lumbar puncture and cancer chemotherapy [2].
P. aeruginosa has many virulence factors like hy-
drolytic enzymes, exotoxin A and endotoxin which 
are produced from the lipopolysaccharide compo-
nent of its cell wall, phospholipases, exoproteases, 
phenazines, outer membrane vesicles; type III secre-
ted effectors, flagella and pili [3]. These factors are 
contributing for the establishment of its infection. 
In addition, these factors can damage the epithelial 
cell lining, induce modifications in cell physiology, 
and function such as cell shape, membrane permea-
bility and protein synthesis [4]. 
Previous work by Willcox in 2007 reported that 
P. aeruginosa coordinates the expression of viru-
lence factors via quorum sensing [5]. It activates 
several pathways of the immune system e.g., it 
activates corneal epithelial cells receptors the toll 
like receptor. Based on activation, recognition of P. 
aeruginosa lipopolysaccharide or flagella and acti-
vation of the epithelial cells takes place, which leads 
to production of inflammatory mediators such as 
cytokines and chemokines. These are also recrui-
ting polymorphonuclear leukocytes (PMNLs) to the 
site of infection to phagocytize and kill the P. aeru-
ginosa. Nevertheless, continued recruitment and 
presence of these PMNLs in the corneal tissue and 
the production of proteases leads to destruction 
of corneal cells and tissue components. Moreover, 
it causes scarring and vision loss. It was concluded 
by Willcox that P. aeruginosa is considered as the 
most common cause of microbial keratitis [5]. 
The biofilm forming ability of P. aeruginosa, which 
is also considered as a virulence factor, contributes to 
the severity of cystic fibrosis (CF) disease [6]. Sagel, 
Gibson et al observed the increase in CF severity, 
lung inflammation and as a result, lung damage in 
patients infected with P. aeruginosa and Staphylo-
coccus aureus [7]. A study showed that the presen-
ce of Gram-positive bacteria leads to up regulation 
of four molecules in P. aeruginosa, which are LasB 
elastase, rhamnolipids, exotoxins, and phenazines 
[8]. Development of biofilms can be associated with 
certain organisms everywhere in nature as well as in 
industrial and clinical environments such as dental 
plaques. More than 700 species of microorganisms 
were identified in extracellular polymeric substances 
(EPS) [9]. 
LasB elastase is a protease produced extracellu-
larly by P. aeruginosa. It can digest the lung surfac-
tant, the pulmonary antimicrobial enzyme lysozyme, 
and transferrin; additionally, it can hinder the ciliary 
movement [10]. Moreover, LasB protease interferes 
with macrophages engulfment and contributes to 
lung tissue injury, detraction of pulmonary action 
and allows the organism spreading to the bloods-
tream [11]. 
Rhamnolipids of P. aeruginosa are glycolipid bio-
surfactants. It solubilizes phospholipids so deteriora-
tion of lung surfactant activity occurs. It disrupts the 
PMNLs chemotaxis and macrophage function, and 
inhibits ciliary beating which leads to interference 
with airway immune response. Furthermore, rham-
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nolipids stimulate the airway epithelium to liberate 
IL-6 and IL-8 pro-inflammatory cytokines, which 
leads to inflammation [12]. 
The fourth molecule "phenazines", are pigments 
associated with cystic fibrosis disease development. 
The manufacturing of pyocyanin, which is the most 
dominant phenazine, participates in excess pro-
duction of goblet cell, airway fibrosis and alveolar 
airspace devastation [11]. Pyocyanin production by 
P. aeruginosa disrupts the equilibrium of T helper 
signaling molecules leading to excess generation of 
IL-4 and IL-13. These two molecules are cytokines 
produced by Th2 and rise in the leakage of ma-
crophage. The cytotoxic and immune modulatory 
effects of these cytokines lead to increased tissue 
damage and help P. aeruginosa survival. This immu-
ne alteration and elusion by many bacterial species 
may be the cause poor patient prognosis with in-
fection by more than one species [8]. 
Increased virulence of P. aeruginosa in humans 
is accompanied by type three secretion (T3SS) ex-
pression [12]. These shoot exotoxins, macrophages 
and epithelial cells, causing excessive inflammatory 
response and associated tissue damage [10]. 
Pseudomonas aeruginosa is the most common 
cause of burns and intensive care units' infections 
[14]. Jackson, Lowbury et al., reported that the 
colonization of burn sites by P. aeruginosa was 
responsible for graft failure, delayed healing and 
systemic complications [13]. P. aeruginosa burn 
infection may lead to an invasive infection and 
potentially fatal sepsis [15]. Therefore, it is essen-
tial to minimize the numbers of Pseudomonas in 
burns. Additionally, the new emergence of multi-
drug resistant strains of P. aeruginosa has further 
increased the urgency to discover more effective 
inhibitory agents [16]. 
Pseudomonas aeruginosa and Biofilm
Biofilm formation is a microbial complex mass in 
which cells are irreversibly attached to a substratum 
and embedded in a matrix of extracellular polysac-
charide substances that they have produced. They 
can grow in and on living tissue, indwelling medical 
devices, industrial or portable water piping system 
and on solid surfaces [17]. 
Environmental signals stimulate switching of 
planktonic into biofilms which usually begins to 
form when a free-swimming bacteria attaches to a 
surface 18]. During this switch, many changes occur 
which include new phenotypic characteristics [18]. 
Also changes in gene expression [19] and genetic 
reprogramming that leads to a sessile lifestyle is the 
repression of flagella gene expression [19]. 
Some minerals like calcium, iron and copper can 
motivate biofilm formation and growth. When cal-
cium concentration was increased to 80 ppm, the 
biofilm forming ability of P. aeruginosa was increa-
sed by 50% [20]. Components of Gram-negative 
bacteria, such as colanic acid alginate of Escheri-
chia coli, glucose and mannose-rich components of 
P. aeruginosa play important roles in the biofilm 
formation. These byproducts construct and provide 
support for development of bacterial biofilms [19]. 
Biofilm matrix
The architectural structure and mechanical stability 
of the biofilms is due to the extracellular matrix [21]. 
Many factors infleunce the composition of biofilm 
matrices like the type of microorganisms and growth 
conditions. But in general, it consists of exopolysac-
charides, proteins, and nucleic acids. Proteinaceous 
components include cell surface adhesins, protein 
subunits of flagella and pili, secreted extracellular 
proteins and proteins of outer membrane vesicles 
[22]. 
Every componenet in the matrix has significant 
function in the biofilm formulation. In 2006, a study 
demonstrated evidence that the absence of TasA 
or the exopoly-saccharide which are major compo-
nents of Bacillus subtilis matrix led to complete fai-
lure to form complex multicellular communities [23]. 
Another study was conducted in 2019 showed 
that, stabilization of S. aureus biofilms are due to 
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the positively charged cytoplasmic proteins that are 
liberated into the extracellular environment, where 
they make favorable electrostatic interactions with 
the negatively charged cell surface and extracellular 
DNA (eDNA) [24]. It was clarified that polysacchari-
de synthesis locus (Psl polysacaride) is a key element 
in EPS matrix of P. aeruginosa biofilm. It promotes 
cell–cell interactions and assembly of a matrix. Lec 
A and Lec B are produced by P. aeruginosa have 
affinities towards sugars pesent in the extracellular 
polymeric substance (EPS) matrix and contribute to 
the attachment of P. aeruginosa to specific host 
cells [25]. Binding of LecB to Psl participates in the 
retention of cells and EPS in a resurgent biofilm [26]. 
Chemical dissociation of Psl from the bacterial sur-
face disrupted the Psl matrix as well as the biofilm 
structure [25]. 
Development of a biofilm
Microbial behavior has been well understood by re-
search through the recognition of diverse characte-
ristics of biofilms. Biofilm development on any sur-
face includes five regular consecutive steps. Several 
bacterial and/or environmental factors influence the 
formation of biofilm, which is a dynamic and com-
plex process [27]. 
These environmental signals diverge among orga-
nisms. Some can form biofilms under any conditions 
that permit growth like P. aeruginosa and P. fluo-
rescens. While others are producing biofilms only 
when minimal medium supplemented with amino 
acids like some strains of Escherichia coli K-12 and 
Vibrio cholera. Unlike E. coli O517:H7 which form 
a biofilm exclusively in media containing few nu-
trients [28]. Moreover, temperature, osmolality, pH, 
iron, and oxygen are other cues that can affect the 
biofilm formation beside the nutrient requirements 
[18]. 
The interaction between environmental and bac-
terial factors is important for the first step, primary 
reversible adhesion of the planktonic bacteria to the 
surface. This based on an equilibrium of attractive 
and repulsive power between the bacteria and the 
surface. Additionally, flagella-driven motility is a re-
markable agent through the primary step of the 
biofilm production for example K12 strains of E. coli 
lacking flagella do not produce biofilms. Additiona-
lly, Chen and collaborators recently suggested that 
flagella-driven motility is also involved in biofilm for-
mation of non-O157:H7 STEC [29]. The existence of 
surface installation like fimbrial adhesins influences 
the irreversible adhesion which is the second step 
in biofilm formation. For example, the attachment 
of shiga toxin producing E. coli (STEC) to surfaces 
conducted by many classes of fimbriae like type 1 
fimbriae, type 4 pili, long polar fimbriae and F9 fim-
briae [30]. 
The third step in biofilm formation is the de-
velopment of micro colonies by the adhered 
microorganisms. The fourth step is excretion of 
extracellular polymeric substances (EPS) and de-
velopment of a three-dimensional mature biofilm 
community. During biofilm maturation, bacteria 
continue to multiply and produce extracellular 
matrix. At this stage, the biofilm adopts a three-
dimensional structure. This growth is mostly due 
to bacterium-bacterium cell interactions; several 
surface proteins and extracellular matrix compo-
nents are involved in bacterial adhesion and bio-
film architecture [31]. 
The final step in the biofilm formation cycle is 
its destruction, microbes detach and spread in to 
the environment to explore and colonize to new 
surfaces (Figure 1) [27]. Starvation is one possi-
ble signal for detachment; the details are not yet 
clear. (GA O’Toole, unpublished data) but Boyd & 
Chakrabarty clarified that the enzyme alginate lya-
se contribute in the detachment phase in P. aeru-
ginosa and increased production of alginate lyase 
could accelerate dispersion and cell liberation from 
biofilms [32]. One study conducted by Allison and 
colleagues stated that loss of EPS leads to reduc-
tion in the biofilm of P. fluorescens after extended 
incubation [33]. 
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Formation of EPS in which the microbial cells 
embedded is a prominent and unrivaled character 
of biofilms. Antimicrobial resistance is attributed to 
EPS; the scaffold for the biofilm [35]. 
The Formation of biofilms by 
P. aeruginosa and emergence of 
antimicrobial resistance
Biofilms have a detrimental action on human health. 
Bacterial biofilms can cause chronic infection(s) such 
as periodontal disease, chronic acne and osteomye-
litis, and cystic fibrosis [36]. Biofilms are seen in 
patients infected with P. aeruginosa, medical im-
plantation infected with Staphylococcus aureus or 
Staphylococcus epidermids [36].
Biofilms display complicated structure consists of 
pillar-like, mature macro colonies hedged by chan-
nels completed with fluid [37]. The unique asset of 
these macro colonies is their polymicrobial mix and 
their collaborative protective outcome(s) that diver-
se species of bacteria can provide to each other. 
For instance, antimicrobial resistant bacteria can 
secrete special enzymes or antimicrobial binding 
proteins that can shield adjacent non-antimicrobial 
resistant bacteria in a biofilm, at the same time 
it can transfer genes to other non-resistant bac-
teria to confer antimicrobial resistance, even bet-
ween different species, horizontal gene exchan-
ge is greatly increased in biofilms [38]. Therefore, 
biofilms are linked to the emergence and spread 
of antibiotic resistant bacteria whereas horizontal 
gene transfer encourages evolution and genetic 
diversity of biofilms.
The highly polymicrobial populated biofilms, in 
comparison to a planktonic mode of growth, am-
plifies the total numbers of antimicrobial resistant 
mutants that can be chosen under antimicrobial 
pressure. Additional survival mechanism that nu-
merous bacteria in biofilms have adapted is for a 
subpopulation to become metabolically inactive. 
Since antimicrobials act on metabolically active bac-
teria, the inactive bacteria in biofilms will remain 
unaffected by antimicrobials [38]. The EPS matrix 
restricts certain antimicrobial agents' diffusion from 
Figure 1: Stages of biofilm formation [34].
Source: research data
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the surrounding into the biofilm. For example, it 
prevents the passage of certain classes of antibio-
tics especially those hydrophilic and positively char-
ged ones, example; aminoglycosides. Therefore, 
several characteristics make biofilm formation is an 
essential tool and mechanism for antibiotic resistan-
ce, transfer of resistance plasmids and conjugative 
transposons, and a medium for intercellular com-
munication (Quorum sensing) [38]. Thus, infection 
with multidrug resistant (MDR) strains of P. aerugi-
nosa could present important threat to hospitalized 
patients in intensive care units [39]. MDR pumps 
play a role in biofilm resistance at low antimicrobial 
concentrations and there is a reason to believe that 
unknown MDR pumps might be overexpressed in 
P. aeruginosa biofilms [40]. 
Many factors help biofilm growth, for instance, 
increased level of mutations as well as with quo-
rum-sensing-regulated mechanisms. Conventio-
nal resistance mechanisms such as chromosomal 
β-lactamase, up-regulated efflux pumps and mu-
tations in antimicrobial target molecules in bacte-
ria also contribute to the survival of biofilms [41]. 
Meanwhile, a study carried out by Haddadin et 
al. 2010 [42] showed a weak association between 
multiple drug resistance P. aeruginosa and strength 
of attachment to stainless steel surfaces. While an 
Indian study conducted on clinical isolates reported 
that 57% of biofilm producing P. aeruginosa were 
multidrug resistant (MDR). These isolates were resis-
tant to aminoglycoside, beta-lactam group of anti-
biotics and fluoroquinolones, respectively. Whereas, 
non-biofilm producing P. aeruginosa showed 20% 
resistance to the same group of antibiotics [43].
A more recent study done by Redfern et al. 2020 
[44], showed that the majority of MDR infections 
are caused by a slight number of “high-risk” clones 
that recently surfaced and spread worldwide. Using 
genome-wide and pan-genome wide association 
techniques, the study detected and verified poten-
tial essential genes involved in biofilm production 
and survival of P. aeruginosa. 
Biofilms can be prevented by early aggressive an-
timicrobial prophylaxis or therapy and they can be 
treated by chronic suppressive therapy. The use of 
enzymes that can dissolve the biofilm matrix (e.g. 
DNase and alginate lyase) as well as quorum-sen-
sing inhibitors that increase biofilm susceptibility to 
antimicrobials [45]. Thus, it could be generally con-
cluded that biofilm is an important feature of viru-
lence factors of any type of bacteria that can make 
a biofilm matrix, including P. aeruginosa.
Biofilm in human wounds 
One to 2% of the population of developing coun-
tries has chronic wounds such as neuropathic foot 
ulcers, arterial ulcers, pressure injures and venous 
ulcers. It represents serious nuisance to patients 
because it is related to severe patient sufferance, 
depravation of job, decreased goodness of life and 
elevated expense to the health care system [46]. 
Wound infection lengthens the cure or recovery; 
treatment involves antibiotic management, elimina-
tion of necrotic tissues, suitable blood and oxygen 
supplying to the wound [47]. Recent studies show 
the presence of bacterial biofilms in chronic wounds 
[48]. This presence may be the cause of impaired 
and delayed wound healing [49] since leukocytes 
surrounding the biofilm prevent the healing of the 
wounds, and inflammatory cells produce protea-
ses, which damage normal and healing tissues 
and immune cells [50]. P. aeruginosa in biofilms 
migrates via type IV pili and flagellum-mediated [51] 
and produces virulence factors that can hold back 
the action of host defense and protection systems 
[49]. It may explain the presence of these bacte-
ria in the deeper regions of chronic wounds [52]. 
Wound healing influenced by many factors that can 
delay healing, but the diagnosis and management 
of wound infection is controversial and varies bet-
ween clinicians.
Finally, an assessment of the factors affecting the 
progression from colonization to infection can help 
clinicians with the interpretation of clinical findings 
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and microbiological investigations in patients with 
chronic wounds. An understanding of the physio-
logy and interactions within multi-species biofilms 
may introduce more effective methods of treating 
infected and poorly healing wounds. Presence of 
consensus guidelines has helped to optimize clinical 
management [50]. 
Quorum sensing
Quorum sensing (QS) is a social behavior exhibited 
by bacterial strains whereby chemical-based com-
munication modulates behavior of the aggregates 
of bacteria. It is the control of gene expression in 
response to cell density and it involves the produc-
tion and detection of extracellular signaling mo-
lecules called auto inducers [53]. Accumulation of 
a minimal threshold stimulatory concentration of 
these auto inducers leads to the alteration of gene 
expression. By using these signal-response systems, 
bacteria concur specific behaviors on a population-
wide scale and thus function as multicellular orga-
nism [54]. 
Researchers recognized many chemical classes of 
microbial signaling molecules produced by micro-
bes Table 1. In general, Gram-negative bacteria use 
mostly N-acyl homoserine lacton (AHL) molecules 
(autoinducer-1, AI-1) while Gram-positive bacteria 
use primarily peptides (auto-inducer peptides, AIP 
or quorum sensing peptides) [55]. Communication is 
important for bacteria to organize several physiolo-
gical activities such as symbiosis, virulence, compe-
tence, conjugation, antibiotic production, motility, 
sporulation, and biofilm formation [56]. The main 
role of quorum sensing is to control the physiology 
of bacterial populations. This control is often done 
at the interface of different bacterial populations or 
at the bacterial-host margin [57]. 
Pseudomonas aeruginosa as a model of 
Quorum sensing 
P. aeruginosa is an opportunistic pathogen, it uses 
a regulatory process called quorum sensing (QS) 
which organizes gene transcription according to cell 
density [63]. There are two major acyl-homoserine 
lactone (AHL) QS systems to P. aeruginosa: the 
LasR-LasI system and the RhlR-RhlI system. LasI and 
RhlI are signal synthases. LasI produces N-3-oxo-
dodecanoyl-homoserine lactone (3OC12-HSL) and 
RhlI produces N-butanoyl-homoserine lactone (C4-
HSL) [86-88]. The increase in cell densities leads to 
increase in the concentrations of these signals. The 
activation of transcription factors occurs in response 
to binding of 3OC12-HSL to LasR and of C4-HSL 
to RhlR. Because of activation of LasR and RhlR, 
Table 1.  Examples of bacterial quorum sensing systems and their controlled social traits.
Microorganisms Average Group-Derived Benefits Reference
Bacillus subtlis ComP/ComARap 
proteins
Competence, sporulation, biofilm formation, antimicrobial 
production,
[58]





Structured biofilm formation, virulence factors [59]




Bacteriocins, biofilm formation, competence [61]




Bioluminescence emission, symbiosis [62]
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the transcription of hundreds of genes is regulated. 
Also, QscR is a third counter regulatory AHL in P. 
aeruginosa [64]. It binds to 3OC12-HSL and to se-
veral other long-chain AHLs [65]. Improvement of 
LasR activation can be achieved by deletion of QscR 
[89-90]; it was detected by observing the earlier 
manufacturing of 3OC12-HSL and C4-HSL and pyo-
cyanin [64]. 
A study demonstrated that QscR regulates 424 
genes. This conclusion was reached by transcripto-
me analysis of a QscR-null mutant in comparison 
to the wild type [66]. QscR, which delay expression 
of LasR or RhlR-activated genes, is QS anti-activa-
tor in P. aeruginosa [67]. QteE and QslA are other 
anti-activator proteins that are not homologous to 
LasR or RhlR and do not bind AHL signals. They 
physically deactivate the ability of LasR and RhlR to 
induce gene transcription [67]. Several hypotheses 
have been in advance to detect the mechanism 
of QscR effects on the timing of AHL QS in P. 
aeruginosa. One study suggested that QscR alters 
the levels of lasI [64]. QscR could work through 
sequestering signal away from LasR. Ledgham et 
al. reported that overexpression in E. coli leads to 
the formation of inactive heterodimers with LasR 
by QscR which could postpone QS gene activation 
[68]. One recent study illustrated that there are 
four main pathways of QS dependent signaling 
present in P. aeruginosa. Each system consists of 
at least two major functional elements category of 
proteins [69]. It was concluded that P. aeruginosa 
QS system is complex due to its multiple inputs 
and transcription factors [70]. 
QS and antimicrobial resistance
The relationship between QS and antibiotic toleran-
ce is multi-faceted because QS includes a universal 
alteration in bacterial gene expression and cell phy-
siology. For instance, the supplement of AHLs to a 
logarithmic culture of P. aeruginosa was shown to 
elevate the number of persister cells in the popu-
lation after treatment with carbenicillin and cipro-
floxacin [71]. The presence of the rhl, and las QS 
systems in 
 P. aeruginosa are important for the biofilm pro-
duction and their disturbance is associated with 
a higher sensitivity to the host immune system 
and antimicrobial compounds [72]. Moreover, P. 
aeruginosa has another QS system; the pqs sys-
tem, which has been demonstrated to mediate 
a programmed cell death inducing extracellular 
DNA release, which promotes biofilm formation 
and antibiotic tolerance, benefitting the rest of the 
cell population [73]. The regulation effect of QS 
system on the expression of multidrug-resistant 
pumps is that both the expression of multidrug-
resistant pumps can be regulated, and the QS sys-
tem itself is also affected by the expression level 
of multidrug-resistant pumps. High expression of 
the efflux pump may promote the further activa-
tion of the QS system, promote the QS system’s 
regulation of toxin infection factor synthesis and 
efflux pump expression, and enhance the infecti-
vity and invasiveness of bacteria [73]. At the same 
time, researchers have found that the QS system 
regulates biofilm-forming genes and regulates bac-
terial resistance-related genes. In the presence of 
imipenem, the resistance gene ampC can be highly 
expressed in biofilms. This situation of high biofilm-
forming bacteria, but low-expression suggests that 
the QS system may also regulate the expression 
of these resistance-related genes while regulating 
biofilm formation. This issue has attracted people’s 
attention and may be another way available for the 
QS system to directly regulate the related genes in 
order to form drug resistance [74].
Mechanism of antibiotic resistance in 
bacterial biofilm
Antibiotic resistance is the microorganism's ability to 
resist the influences of drugs which can inhibit or 
kill their growth. For pathogenic bacteria, the dra-
matic increase in antimicrobial resistance in recent 
decades comprises a key threat to human health 
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[75]. According to the CDC, the world is under a 
threat of entering the “post-antibiotic era”, in which 
the rate of death from bacterial infections is higher 
than from cancer [76]. In the U.S. alone, 2 million 
infections and 23,000 deaths a year resulted from 
antibiotic-resistant bacterial infection and the cost 
of the resistance on economy is about $55–70 bi-
llion per year [77]. Biofilm forming ability of bacteria 
contributes to the antimicrobial resistance that leads 
to many persistent and chronic bacterial infections. 
Inside a biofilm, bacteria can attach to surfaces ag-
gregate in a hydrated polymeric matrix of their own 
synthesis [78]. The biofilm's structural nature and 
sessile cells characteristics a protection environment 
against diverge conditions and the host´s defenses 
[79]. 
Conclusion
Despite decades of research, little is known about 
the molecular mechanisms of antibiotic resistance in 
biofilms [79]. However, a review article by Stewart 
and Costerton in 2014, illustrated that resistance 
and tolerance of biofilm may be due to several 
mechanisms [80]. These include slow penetration 
of antimicrobial agent through the biofilm, alte-
rations in the biofilm chemical microenvironment 
(leading to zones of slow or no growth), response 
to adaptive stress [80-81]. Recently the article of 
Mittal proposed other mechanisms that have a role 
in antibiotic resistance. Poor penetration of antibio-
tics, exopolysaccharide, and degradation of envi-
ronmental DNA (e DNA) in matrix are methods of 
struggling with antibiotic action. In addition, limited 
nutrient, slow growth and persistent cell formation 
make multilevel protections for antibiotic resistance. 
Genetically horizontal gene transfer and higher mu-
tation frequency also display a crucial role in antimi-
crobial resistance in biofilm bacteria [82]. Although 
there are several excellent reviews on anti-microbial 
resistance in biofilms [82], many of them focus on 
a particular organism, a nominated mechanism or 
both. Moreover, it still is unclear whether the me-
chanisms discussed are more important in biofilms 
than in planktonic cells [80]. 
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